Compare Piramal Enterprises with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ALKEM LABORATORIES - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ALKEM LABORATORIES PIRAMAL ENTERPRISES/
ALKEM LABORATORIES
 
P/E (TTM) x -42.2 22.4 - View Chart
P/BV x 1.4 5.4 26.3% View Chart
Dividend Yield % 1.6 0.9 181.8%  

Financials

 PIRAMAL ENTERPRISES   ALKEM LABORATORIES
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ALKEM LABORATORIES
Mar-20
PIRAMAL ENTERPRISES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3,3032,720 121.4%   
Low Rs1,7971,660 108.2%   
Sales per share (Unadj.) Rs716.5697.9 102.7%  
Earnings per share (Unadj.) Rs79.796.1 82.9%  
Cash flow per share (Unadj.) Rs107.9117.3 92.0%  
Dividends per share (Unadj.) Rs28.0025.00 112.0%  
Dividend yield (eoy) %1.11.1 96.2%  
Book value per share (Unadj.) Rs1,477.5515.2 286.8%  
Shares outstanding (eoy) m184.45119.57 154.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.63.1 113.4%   
Avg P/E ratio x32.022.8 140.4%  
P/CF ratio (eoy) x23.618.7 126.5%  
Price / Book Value ratio x1.74.3 40.6%  
Dividend payout %35.126.0 135.1%   
Avg Mkt Cap Rs m470,292261,879 179.6%   
No. of employees `0007.814.3 54.6%   
Total wages/salary Rs m22,50415,055 149.5%   
Avg. sales/employee Rs Th16,899.45,822.6 290.2%   
Avg. wages/employee Rs Th2,877.71,050.5 273.9%   
Avg. net profit/employee Rs Th1,879.9802.0 234.4%   
INCOME DATA
Net Sales Rs m132,15383,444 158.4%  
Other income Rs m3,1281,042 300.1%   
Total revenues Rs m135,28184,486 160.1%   
Gross profit Rs m66,29014,734 449.9%  
Depreciation Rs m5,2022,528 205.8%   
Interest Rs m44,097651 6,778.0%   
Profit before tax Rs m20,11912,598 159.7%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6111,105 779.4%   
Profit after tax Rs m14,70111,493 127.9%  
Gross profit margin %50.217.7 284.1%  
Effective tax rate %42.88.8 488.1%   
Net profit margin %11.113.8 80.8%  
BALANCE SHEET DATA
Current assets Rs m122,74254,960 223.3%   
Current liabilities Rs m310,81032,433 958.3%   
Net working cap to sales %-142.327.0 -527.1%  
Current ratio x0.41.7 23.3%  
Inventory Days Days2380 29.0%  
Debtors Days Days3972 53.8%  
Net fixed assets Rs m116,90432,710 357.4%   
Share capital Rs m369239 154.3%   
"Free" reserves Rs m272,16161,368 443.5%   
Net worth Rs m272,53061,607 442.4%   
Long term debt Rs m270,1961,592 16,967.9%   
Total assets Rs m856,26199,433 861.1%  
Interest coverage x1.520.4 7.2%   
Debt to equity ratio x1.00 3,835.7%  
Sales to assets ratio x0.20.8 18.4%   
Return on assets %6.912.2 56.2%  
Return on equity %5.418.7 28.9%  
Return on capital %12.421.0 59.2%  
Exports to sales %019.1 0.0%   
Imports to sales %03.0 0.0%   
Exports (fob) Rs mNA15,917 0.0%   
Imports (cif) Rs mNA2,483 0.0%   
Fx inflow Rs m15,20016,061 94.6%   
Fx outflow Rs m4,8892,483 196.9%   
Net fx Rs m10,31213,578 75.9%   
CASH FLOW
From Operations Rs m-115,9755,851 -1,982.2%  
From Investments Rs m-8,265-7,414 111.5%  
From Financial Activity Rs m107,525792 13,584.9%  
Net Cashflow Rs m-16,650-731 2,277.4%  

Share Holding

Indian Promoters % 52.9 66.9 79.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 33.1 12.1%  
FIIs % 26.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 0.0 -  
Shareholders   93,274 68,381 136.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   NEULAND LABS  DR. REDDYS LAB  GSK PHARMA  ALEMBIC  PROCTER & GAMBLE HEALTH  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Apr 16, 2021 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - SANOFI INDIA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS